 |
Digital therapeutics (DTx) offer a new opportunity for life science organizations (LSOs) to better serve and support patients. By leveraging DTx, LSOs increase access to clinically safe and effective therapies for their patients, including underserved or disadvantaged populations. Patient engagement optimizes digital therapy outcomes and is a critical component of the patient treatment plan. LSOs are quickly expanding accessibility to innovative DTx, and patient engagement software improves the overall quality of care with these treatment options. In this guide, you’ll learn how to:
|
